SecBot SecBot
8-K ·Filed Nov 5, 2026

BDX

BECTON DICKINSON & CO
BULLISH
Impact 6/10
Horizondays Processed11d 15h ago SEC0001628280-26-070511
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

BD delivered a strong Q4 beat on both revenue and EPS, with notable FCF acceleration. FY27 adjusted EPS guidance of $13.10-$13.30 implies ~3.1-4.7% growth from FY26 adjusted EPS of $12.70. The $19B U.S. manufacturing partnership with tariff relief is a strategic positive. Watch the December 10 Investor Day for further strategic and capital allocation details.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$213.55
T+0 close · Nov 5, 2026 · via day close
Latest settled
+1.01%
T+5 · $215.71
Vs SPY
−2.28%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $213.55entry
  2. T+1 · 11d ago −0.78%α −1.09% · $211.88
  3. T+5 · 5d ago +1.01%α −2.28% · $215.71
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BD reported Q4 FY2026 revenue of $5.274B (up 5.4% YoY, 5.6% FXN) and adjusted diluted EPS of $4.15, above the $4.07 consensus. FY26 cash from continuing operations rose 30% to $3.6B and free cash flow increased 42.5% to $2.9B. The company issued FY27 adjusted EPS guidance of $13.10-$13.30, implying low single-digit revenue growth.

Key Financial Metrics

EPS (Adj.)
$4.15
est $4.07 · +2.0% · GAAP: $2.52
Revenue
$5.3B
est $5.1B · +3.2% · +5.4% YoY
Rating
in line
Guidance
low single-digit
maintained
Free Cash Flow
$2.9B

Key Facts

  • Q4 revenue $5.274B, +5.4% reported, +5.6% FXN vs prior year
  • Q4 GAAP diluted EPS $2.52, adjusted diluted EPS $4.15
  • Adjusted EPS $4.15 beat consensus of $4.07 (surprise +2.0%)
  • Revenue $5.274B beat consensus of $5.11B (surprise +3.2%)
  • FY26 revenue $19.457B, +4.9% reported, +3.9% FXN
  • FY26 adjusted diluted EPS $12.70, vs prior guidance $12.52-$12.72
  • FY26 cash from continuing ops $3.605B, +30.0%; free cash flow $2.933B, +42.5%
  • FY27 adjusted EPS guidance $13.10-$13.30, revenue growth low single-digit
  • Announced $19B U.S. manufacturing investment partnership with U.S. Government

Financial Impact

Q4 revenue beat by $164M (+3.2% vs consensus); adjusted EPS beat by $0.08 (+2.0% vs consensus); FY26 FCF $2.933B (+42.5% YoY)

revenueepscash flowguidance

Segment Breakdown

SegmentRevenueGrowth
Medical Essentials$1.8B+5.9%
Connected Care$1.3B+1.6%
BioPharma Systems$748.0M+6.5%
Interventional$1.5B+7.6%

Risk Factors

  • FY27 revenue guidance of low single-digit growth implies deceleration from FY26's 4.9% reported growth
  • FY27 adjusted EPS guidance midpoint of $13.20 is only ~3.9% above FY26 adjusted EPS of $12.70
  • Tariff and trade policy uncertainty remain, though the U.S. government partnership provides some relief
  • Connected Care segment Q4 revenue growth was only 1.6% reported (2.1% FXN), with Medication Management Solutions declining 2.3% reported

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
57% bullish (21 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-070511
Document: bdx-20261105.htm0001628280-26-070511
Document: 0001628280-26-070511-index-headers.html0001628280-26-070511
Document: 0001628280-26-070511-index.html0001628280-26-070511
Document: 0001628280-26-070511.txt0001628280-26-070511
8-K Data (Synthetic)0001628280-26-070511

Track record

17 reports on BDX

Performance horizon
Filters
  1. Nov 10, 20266d ago 144 Neutral 2/10 Entry $214.52 Now $216.47 +0.91% settles Nov 18
  2. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $211.88 to $218.03 Now $216.47 +2.17% ▲ +2.90% +0.31% vs SPY
  3. Nov 5, 202611d ago 144 Neutral 2/10 Entry $211.88 to $218.03 Now $216.47 +2.17% ▲ +2.90% +0.31% vs SPY
  4. Nov 5, 202611d ago 8-K Bullish 6/10 Viewing Entry $213.55 to $215.71 Now $216.47 +1.37% ▲ +1.01% −2.28% vs SPY
  5. Nov 5, 202611d ago Press Release Neutral 3/10 Entry $213.55 to $215.71 Now $216.47 +1.37% ▲ +1.01% −2.28% vs SPY
  6. Nov 4, 202612d ago Press Release Neutral 2/10 Entry $209.19 to $214.52 Now $216.47 +3.48% ▲ +2.55% +3.46% vs SPY
  7. Oct 26, 202621d ago 144 Neutral 2/10 Entry $195.03 to $198.17 Now $216.47 +10.99% ▲ +1.61% +3.60% vs SPY
  8. Oct 6, 20265w ago Press Release Neutral 2/10 Entry $180.30 to $187.37 Now $216.47 +20.06% ▲ +3.92% +4.06% vs SPY
  9. Aug 14, 202613w ago Insider Cluster Neutral 2/10 Entry $182.09 to $190.74 Now $216.47 +18.88% ▲ +4.75% +5.94% vs SPY
  10. Jul 22, 202616w ago 8-K Neutral 2/10 Entry $153.16 to $168.40 Now $216.47 +41.34% ▲ +9.95% +12.35% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens Wed (11h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026